{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:44:49Z","timestamp":1786635889171,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0253-7613.62409","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T02:13:15Z","timestamp":1271902395000},"page":"32","source":"Crossref","is-referenced-by-count":22,"title":["Effective control of sickle cell disease with hydroxyurea therapy"],"prefix":"10.4103","volume":"42","author":[{"given":"Harminder","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Dulhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BithikaNel","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.62409-1","first-page":"552","volume-title":"Pathways of innovation: A history of the first effective treatment for sickle cell anemia","author":"Williams","year":"2004","journal-title":"Perspect Biol Med"},{"key":"key-10.4103\/0253-7613.62409-2","first-page":"18","volume-title":"Bone marrow transplantation for sickle cell disease: The European experience","author":"Vermylen","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"key-10.4103\/0253-7613.62409-3","first-page":"1317","volume-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia: Investigators of the multicenter study of hydroxyurea in sickle cell anemia","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0253-7613.62409-4","doi-asserted-by":"crossref","unstructured":"Rosse WF, Narla M, Petz LD, Steinberg MH. New views of sickle cell disease pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2000. p. 2-17.","DOI":"10.1182\/asheducation-2000.1.2"},{"key":"key-10.4103\/0253-7613.62409-5","first-page":"1787","volume-title":"Induction of fetal hemoglobin in sickle cell disease","author":"Bunn","year":"1999","journal-title":"Blood"},{"key":"key-10.4103\/0253-7613.62409-6","first-page":"1550","volume-title":"Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study: A phase I\/II trial.Pediatric Hydroxyurea Group","author":"Kinney","year":"1999","journal-title":"Blood"},{"key":"key-10.4103\/0253-7613.62409-7","first-page":"3022","volume-title":"Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease","author":"Ware","year":"1999","journal-title":"Blood"},{"key":"key-10.4103\/0253-7613.62409-8","first-page":"96","volume-title":"Levels of fetal hemoglobin necessary for treatment of sickle cell disease","author":"Noguchi","year":"1988","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0253-7613.62409-9","first-page":"11","volume-title":"Pain in sickle cell disease: Rates and risk factors","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0253-7613.62409-10","first-page":"1645","volume-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"key-10.4103\/0253-7613.62409-11","first-page":"559","volume-title":"Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia","author":"Jayabose","year":"1996","journal-title":"J Pediatr"},{"key":"key-10.4103\/0253-7613.62409-12","unstructured":"The Management of Sickle Cell Disease. National Heart Lung and Blood Institute. Revised 6\/2002. Available from: http:\/\/www.nhlbi.nih.gov\/health\/prof\/blood\/sickle\/sc_mngt.pdf. [accessed on 2008 Apr 13]."},{"key":"key-10.4103\/0253-7613.62409-13","first-page":"2555","volume-title":"Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia","author":"Charache","year":"1992","journal-title":"Blood"},{"key":"key-10.4103\/0253-7613.62409-14","first-page":"231","volume-title":"Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase","author":"Cokic","year":"2003","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0253-7613.62409-15","first-page":"436","volume-title":"Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease","author":"Gladwin","year":"2002","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0253-7613.62409-16","unstructured":"A biannual newsletter of regional medical research centre for tribals, Jabalpur, April 2005. Available from: http:\/\/icmr.nic.in\/000519\/Newsletter_vol2No1.pdf. [accessed in 2009]."},{"key":"key-10.4103\/0253-7613.62409-17","first-page":"1960","volume-title":"Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial","author":"Ferster","year":"1996","journal-title":"Blood"},{"key":"key-10.4103\/0253-7613.62409-18","first-page":"3628","volume-title":"Five years of experience with hydroxyurea in children and young adults with sickle cell disease","author":"Ferster","year":"2001","journal-title":"Blood"},{"key":"key-10.4103\/0253-7613.62409-19","first-page":"1427","volume-title":"Bone marrow transplantation in 5 children with sickle cell anemia","author":"Vermylen","year":"1988","journal-title":"Lancet"},{"key":"key-10.4103\/0253-7613.62409-20","first-page":"18","volume-title":"Bone marrow transplantation for sickle cell disease: The European experience","author":"Vermylen","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"key-10.4103\/0253-7613.62409-21","first-page":"1317","volume-title":"Effects of hydroxyurea on the frequency of painful crises in sickle cell anemia","author":"Charache","year":"1995","journal-title":"N Eng J Med"},{"key":"key-10.4103\/0253-7613.62409-22","first-page":"2555","volume-title":"Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia","author":"Charache","year":"1992","journal-title":"Blood"},{"key":"key-10.4103\/0253-7613.62409-23","first-page":"295","volume-title":"Hydroxyurea therapy in 49 patients with major beta thalassemia","author":"Zamani","year":"2009","journal-title":"Arch Iran Med"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:51:26Z","timestamp":1786632686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.62409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"alternative-id":["62409"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.62409","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}